Botulinum toxin treatment of axial and cervical dystonia
- PMID: 18033602
- DOI: 10.1080/01421590701568262
Botulinum toxin treatment of axial and cervical dystonia
Abstract
Axial truncal dystonia is characterized by an abnormal trunk posture often superimposed by myoclonic motor activities. Cervical dystonia is a motor syndrome characterized by abnormal head and neck posture due to tonic involuntary contractions in a certain set of muscles often superimposed by myoclonic or tremulous movements. Intramuscular injection of botulinum toxin is the first line treatment in cervical dystonia, in axial truncal dystonias botulinum toxin therapy is used only in mild forms. In this review the theoretical background, practical aspects and efficacy results especially in cervical dystonia are presented. Treatment of axial trunk dystonia is only briefly discussed at the beginning of this review.
Similar articles
-
Reply: Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: randomized, double-blind, noninferiority trial.Mov Disord. 2009 May 15;24(7):1098-9; author reply 1100. doi: 10.1002/mds.22339. Mov Disord. 2009. PMID: 18942082 No abstract available.
-
Botulinum toxin therapy for cervical dystonia.Phys Med Rehabil Clin N Am. 2003 Nov;14(4):749-66, vi. doi: 10.1016/s1047-9651(03)00045-7. Phys Med Rehabil Clin N Am. 2003. PMID: 14580035 Review.
-
[Treatment of focal dystonia with botulinum toxin A].Wien Klin Wochenschr. 2001;113 Suppl 4:6-10. Wien Klin Wochenschr. 2001. PMID: 15506045 Review. German.
-
Botulinum toxin in blepharospasm and oromandibular dystonia: comparing different botulinum toxin preparations.Eur J Neurol. 2006 Feb;13 Suppl 1:21-9. doi: 10.1111/j.1468-1331.2006.01441.x. Eur J Neurol. 2006. PMID: 16417594 Review.
-
[Cervical dystonia--diagnosis and treatment].Tidsskr Nor Laegeforen. 2008 Oct 9;128(19):2202-5. Tidsskr Nor Laegeforen. 2008. PMID: 18846145 Review. Norwegian.
Cited by
-
Isolation and quantification of botulinum neurotoxin from complex matrices using the BoTest matrix assays.J Vis Exp. 2014 Mar 3;(85):51170. doi: 10.3791/51170. J Vis Exp. 2014. PMID: 24638074 Free PMC article.
-
Botulinum toxin type A and a rehabilitation program in the treatment of Pisa syndrome in Parkinson's disease.J Neurol. 2010 Jan;257(1):139-41. doi: 10.1007/s00415-009-5310-4. J Neurol. 2010. PMID: 19763384 No abstract available.
-
[Botulinum toxin treatment : therapy success in cases of depression and ongoing pension applications].Nervenarzt. 2009 Jun;80(6):712-6. doi: 10.1007/s00115-009-2690-8. Nervenarzt. 2009. PMID: 19294358 Clinical Trial. German.
-
Detection of botulinum neurotoxin serotype A, B, and F proteolytic activity in complex matrices with picomolar to femtomolar sensitivity.Appl Environ Microbiol. 2012 Nov;78(21):7687-97. doi: 10.1128/AEM.01664-12. Epub 2012 Aug 24. Appl Environ Microbiol. 2012. PMID: 22923410 Free PMC article.
-
Botulinum Neurotoxin-A Injected Intrastriatally into Hemiparkinsonian Rats Improves the Initiation Time for Left and Right Forelimbs in Both Forehand and Backhand Directions.Int J Mol Sci. 2019 Feb 25;20(4):992. doi: 10.3390/ijms20040992. Int J Mol Sci. 2019. PMID: 30823527 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical